TRUEMETRIX
Report
- Report Number
- 1000113657-2016-02081
- Event Type
- Malfunction
- Date Received
- December 23, 2016
- Date of Event
- November 30, 2016
- Report Date
- December 23, 2016
- Manufacturer
- TRIVIDIA HEALTH, INC.
- Product Code
- NBW
- UDI-DI
- 00041220001286
- PMA / PMN Number
- K140100
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX
- Reporter Occupation
- OTHER
Narratives
(B)(4). RETURNED METER EVALUATED WITH NO DEFECT FOUND. TEST STRIPS NOT RETURNED FOR EVALUATION. MOST LIKELY UNDERLYING ROOT CAUSE OF MALFUNCTION: USER HAD AN INACCURATE REFERENCE TEST STRIP UDI#:(B)(4).
CONSUMER REPORTED COMPLAINT FOR HIGH BLOOD GLUCOSE TEST RESULTS. THE CUSTOMER IS CONCERNED WITH TESTS RESULTS FROM RESULTS OBTAINED OF 187MG/DL. THE CUSTOMER'S EXPECTED FASTING BLOOD GLUCOSE TEST RESULT RANGE IS 85 TO 98MG/DL. THE CUSTOMER FEELS WELL AND DID NOT REPORT ANY SYMPTOMS. THE PRODUCT IS STORED ACCORDING TO SPECIFICATION IN THE BEDROOM. MEDICAL ATTENTION IS NOT REPORTED AS A RESULT OF THE ACTUAL BLOOD GLUCOSE RESULTS. DURING THE CALL ON (B)(6) 2016, A BACK TO BACK BLOOD TEST WAS PERFORMED BY THE CUSTOMER FASTING AND PRODUCED TEST RESULTS OF 127 AND 115MG/DL USING TRUE METRIX METER. THE TEST STRIP LOT MANUFACTURER'S EXPIRATION DATE IS 12/31/2017 AND OPEN VIAL DATE IS 11/01/2016. THE METER MEMORY WAS REVIEWED FOR PREVIOUS TEST RESULT HISTORY (DATE / TIME NOT SET): 132MG/DL (B)(6) 2016 12:01 PM FASTING: YES; 131MG/DL (B)(6) 2016 06:45 AM FASTING: YES; 158MG/DL (B)(6) 2016 06:43 AM FASTING: YES; 187MG/DL (B)(6) 2016 06:42 AM FASTING: YES; 129MG/DL (B)(6) 2016 06:28 AM FASTING: YES. CUSTOMER CHANGED EXERCISE ROUTINE; CUSTOMER USED TO WALK TWO MILES AND NOW HE DOES NOT EXERCISE AS MUCH.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 852471 | TRUEMETRIX | BLOOD GLUCOSE SYSTEM | NBW | TRIVIDIA HEALTH, INC. | TRUEMETRIX | MT1874 | 00041220001286 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 0 YR | SECOND THERAPY |